Marshall Wace’s Chemours CC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $27.6M | Buy |
+1,253,283
| New | +$21.8M | 0.03% | 587 |
|
|
2025
Q4 | – | Sell |
-1,254,855
| Closed | -$19.9M | – | 2999 |
|
|
2025
Q3 | $19.9M | Sell |
1,254,855
-1,253,697
| -50% | -$18.2M | 0.02% | 658 |
|
|
2025
Q2 | $28.7M | Sell |
2,508,552
-3,452,586
| -58% | -$38.9M | 0.03% | 451 |
|
|
2025
Q1 | $80.7M | Sell |
5,961,138
-1,124,197
| -16% | -$18.7M | 0.1% | 175 |
|
|
2024
Q4 | $120M | Sell |
7,085,335
-31,619
| -0.4% | -$615K | 0.14% | 116 |
|
|
2024
Q3 | $145M | Buy |
7,116,954
+107,086
| +2% | +$2.19M | 0.18% | 89 |
|
|
2024
Q2 | $158M | Buy |
7,009,868
+1,347,710
| +24% | +$35.3M | 0.21% | 81 |
|
|
2024
Q1 | $149M | Buy |
5,662,158
+1,750,148
| +45% | +$49.9M | 0.23% | 81 |
|
|
2023
Q4 | $123M | Buy |
3,912,010
+2,430,821
| +164% | +$66M | 0.21% | 92 |
|
|
2023
Q3 | $41.5M | Buy |
1,481,189
+924,463
| +166% | +$31.7M | 0.08% | 243 |
|
|
2023
Q2 | $20.5M | Buy |
+556,726
| New | +$17M | 0.04% | 471 |
|
|
2023
Q1 | – | Sell |
-12,809
| Closed | -$392K | – | 2698 |
|
|
2022
Q4 | $392K | Sell |
12,809
-62,024
| -83% | -$1.86M | ﹤0.01% | 2464 |
|
|
2022
Q3 | $1.84M | Sell |
74,833
-6,770
| -8% | -$223K | ﹤0.01% | 2066 |
|
|
2022
Q2 | $2.61M | Sell |
81,603
-134,649
| -62% | -$4.95M | 0.01% | 1800 |
|
|
2022
Q1 | $6.81M | Sell |
216,252
-14,585
| -6% | -$456K | 0.01% | 1161 |
|
|
2021
Q4 | $7.75M | Buy |
230,837
+207,284
| +880% | +$6.46M | 0.01% | 1049 |
|
|
2021
Q3 | $684K | Buy |
+23,553
| New | +$762K | ﹤0.01% | 2235 |
|
|
2020
Q2 | – | Sell |
-7,702
| Closed | -$68K | – | 1583 |
|
|
2020
Q1 | $68K | Buy |
+7,702
| New | +$111K | ﹤0.01% | 1382 |
|
|
2019
Q4 | – | Sell |
-98,293
| Closed | -$1.47M | – | 1727 |
|
|
2019
Q3 | $1.47M | Buy |
+98,293
| New | +$1.6M | 0.01% | 845 |
|
|
2019
Q2 | – | Sell |
-14,646
| Closed | -$544K | – | 1391 |
|
|
2019
Q1 | $544K | Buy |
+14,646
| New | +$533K | 0.01% | 1114 |
|
|
2018
Q4 | – | Sell |
-1,396,422
| Closed | -$55.1M | – | 1602 |
|
|
2018
Q3 | $55.1M | Buy |
1,396,422
+561,484
| +67% | +$24.6M | 0.47% | 35 |
|
|
2018
Q2 | $37M | Buy |
834,938
+753,593
| +926% | +$37.5M | 0.55% | 44 |
|
|
2018
Q1 | $3.96M | Hold |
81,345
| – | – | 0.16% | 127 |
|
|
2017
Q4 | $4.07M | Buy |
+81,345
| New | +$4.26M | 0.17% | 121 |
|
|
2016
Q4 | – | Sell |
-154,519
| Closed | -$2.47M | – | 982 |
|
|
2016
Q3 | $2.47M | Sell |
154,519
-730,362
| -83% | -$8.34M | 0.02% | 552 |
|
|
2016
Q2 | $7.29M | Buy |
884,881
+860,713
| +3,561% | +$7.67M | 0.06% | 316 |
|
|
2016
Q1 | $169K | Buy |
+24,168
| New | +$121K | ﹤0.01% | 981 |
|
Other funds holding CC
VPM
VCM
WHCM
Marshall Wace's CC Position: Q1 2026 in Review
Marshall Wace opened a new position in Chemours (CC) in Q1 2026: 1,253,283 shares worth $27.6M. The stake represents 0.03% of the portfolio and ranks #587 among its holdings. This is a return to the name: Marshall Wace previously reported a position in CC as recently as Q3 2025.
Marshall Wace first reported a position in CC in Q1 2016 and has held it in 27 quarters since. The position peaked at $158M in Q2 2024. 448 funds tracked by Wall St. Rank hold CC as of Q1 2026.
- Marshall Wace held 1,253,283 shares of Chemours worth $27.6M as of Q1 2026.
- Chemours was a new Marshall Wace position in Q1 2026.
- Chemours made up 0.03% of Marshall Wace's portfolio in Q1 2026, its #587 holding.
- Marshall Wace first reported a position in Chemours in Q1 2016 and has held it in 27 quarters since.
- Marshall Wace's Chemours position peaked at $158M in Q2 2024.
- 448 funds tracked by Wall St. Rank held Chemours as of Q1 2026.
Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.